Performance of the EORTC and CUETO Models to Predict Recurrence and Progression in High-risk Non-muscle-invasive Bladder Cancer Patients

CONCLUSION: The CUETO model was superior to the EORTC model in predicting recurrence and progression and stratifying patients with different prognoses in our high-risk NMIBC patient population treated according to current guideline recommendations. However, both models overestimated the probability of disease recurrence and progression. Only the probability of recurrence at five years in the high-risk group of the CUETO model was compatible with our cohort.PMID:38493314 | DOI:10.22037/uj.v20i.7854

Source: Urology Journal - March 17, 2024 Category: Urology & Nephrology Authors: Ya şar Pazır Abdullah Esmeray Mucahit Gelmis Ufuk Caglar Faruk Ozgor Omer Sar ılar Fatih Akbulut Source Type: research